Published in Science on September 10, 1999
Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature (2009) 8.70
Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97
An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science (2008) 4.89
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med (2010) 4.76
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol (2011) 3.70
Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet (2000) 3.64
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med (2008) 3.53
A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol (2008) 3.07
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood (2010) 2.84
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ (2009) 2.30
p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science (2009) 2.11
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle (2009) 2.00
Identification of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res (2009) 2.00
Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest (2005) 1.91
Activation and activities of the p53 tumour suppressor protein. Br J Cancer (2001) 1.90
Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis. Genes Dev (2002) 1.89
siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol (2009) 1.86
HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature (2013) 1.84
Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest (2013) 1.83
PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res (2013) 1.81
Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc Natl Acad Sci U S A (2004) 1.75
Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol (2007) 1.70
5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Genes Dev (2010) 1.64
Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. EMBO J (2010) 1.64
Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood (2007) 1.51
PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc Natl Acad Sci U S A (2009) 1.50
The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression. Cell Death Dis (2014) 1.50
Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature (2014) 1.44
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. EMBO Mol Med (2012) 1.44
Intracellular Theileria annulata promote invasive cell motility through kinase regulation of the host actin cytoskeleton. PLoS Pathog (2014) 1.43
NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget (2011) 1.42
Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev (2006) 1.42
Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. J Clin Invest (2011) 1.42
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J (2002) 1.42
Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes Dev (2005) 1.42
The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival. Mol Cell Biol (2009) 1.40
Pathologies associated with the p53 response. Cold Spring Harb Perspect Biol (2010) 1.40
Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood (2010) 1.38
New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med (2013) 1.35
A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem Biol (2011) 1.35
Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis. Int J Radiat Oncol Biol Phys (2009) 1.34
Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. J Virol (2006) 1.32
Recent advances in p53 research and cancer treatment. J Biomed Biotechnol (2011) 1.31
Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy (2011) 1.30
Exploiting replicative stress to treat cancer. Nat Rev Drug Discov (2015) 1.27
Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem (2011) 1.27
Inflammation and p53: A Tale of Two Stresses. Genes Cancer (2011) 1.27
Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res (2009) 1.27
The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet (2011) 1.27
Targeting p53 for Novel Anticancer Therapy. Transl Oncol (2010) 1.26
Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov (2013) 1.25
Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med (2005) 1.22
Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS One (2011) 1.22
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. J Clin Invest (2000) 1.22
MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis (2012) 1.20
Temozolomide induces senescence but not apoptosis in human melanoma cells. Br J Cancer (2007) 1.20
Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle (2005) 1.20
The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Res (2012) 1.19
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon. Mol Cell Biol (2009) 1.19
ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. Cell Death Differ (2014) 1.18
Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer. J Biol Chem (2011) 1.16
Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J Hepatol (2012) 1.16
Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci U S A (2011) 1.14
Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. J Biol Chem (2011) 1.14
p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia. Cancer Res (2008) 1.14
Emerging strategies to boost thymic function. Curr Opin Pharmacol (2010) 1.12
c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. Br J Cancer (2003) 1.12
BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J Biol Chem (2009) 1.12
Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. Cancer Res (2010) 1.11
Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity. Cell Signal (2014) 1.11
Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer (2006) 1.10
Regulation of neuronal P53 activity by CXCR 4. Mol Cell Neurosci (2005) 1.10
Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. EMBO Mol Med (2012) 1.10
Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res (2008) 1.09
Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol (2002) 1.09
Hematopoietic stem cell injury induced by ionizing radiation. Antioxid Redox Signal (2014) 1.09
p53 and NF-κB coregulate proinflammatory gene responses in human macrophages. Cancer Res (2014) 1.09
Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis (2009) 1.08
The p53 tumor suppressor protein regulates hematopoietic stem cell fate. J Cell Physiol (2011) 1.08
PAX2 suppresses apoptosis in renal collecting duct cells. Am J Pathol (2000) 1.08
Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex. Cereb Cortex (2008) 1.08
PCB126 exposure disrupts zebrafish ventricular and branchial but not early neural crest development. Toxicol Sci (2008) 1.07
Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc Natl Acad Sci U S A (2002) 1.07
Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet (2013) 1.07
Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res (2014) 1.06
Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death. EMBO J (2002) 1.06
p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J (2003) 1.06
A novel function for p53: regulation of growth cone motility through interaction with Rho kinase. J Neurosci (2009) 1.05
Bax, Bcl2, and p53 differentially regulate neomycin- and gentamicin-induced hair cell death in the zebrafish lateral line. J Assoc Res Otolaryngol (2013) 1.05
Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells. Oncogene (2010) 1.04
The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem (2010) 1.04
Clinical status of duplex RNA. Bioorg Med Chem Lett (2010) 1.04
P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. Am J Respir Cell Mol Biol (2005) 1.03
Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J (2009) 1.03
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice. Cell Cycle (2010) 1.01
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma. Cancer Res (2009) 1.01
Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia. Stroke (2008) 1.01
p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts. Cancer Res (2008) 1.01
Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy. PLoS One (2009) 1.01
The p53 network. J Biol Chem (1998) 3.19
The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66
Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J (1997) 1.96
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene (2001) 1.95
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene (2007) 1.77
c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene (2007) 1.59
Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene (1998) 1.40
Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol (2001) 1.39
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36
Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene (2001) 1.36
Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene (2000) 1.35
Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J Biol Chem (2000) 1.31
p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29
Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res (1993) 1.27
P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol (1990) 1.27
MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol (1998) 1.25
9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways. Oncogene (2009) 1.24
p53 modulation of anchorage independent growth and experimental metastasis. Oncogene (1996) 1.23
Forward genetics in mammalian cells: functional approaches to gene discovery. Hum Mol Genet (1999) 1.22
Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene (2008) 1.20
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg (1988) 1.19
Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem (1999) 1.12
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene (2010) 1.11
Applications of green fluorescent protein as a marker of retroviral vectors. Somat Cell Mol Genet (1997) 1.08
The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem Sci (1995) 1.07
Suppression of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry (Mosc) (2000) 1.02
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. Cancer Res (1986) 1.02
Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma? Ann Surg (1985) 1.02
p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene (2000) 1.00
Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett (1998) 1.00
Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus. Cancer Res (1997) 0.99
Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors. Biochem Pharmacol (2001) 0.99
p53-dependent growth arrest of REF52 cells containing newly amplified DNA. Proc Natl Acad Sci U S A (1995) 0.96
Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas. Oncogene (2006) 0.96
Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol (1982) 0.94
Flow cytometric analysis of paraffin-embedded tumors: implications for diagnostic pathology. Hum Pathol (1986) 0.94
Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res (1997) 0.94
ART-CH: a VL30 in chickens? J Virol (1994) 0.93
ART-CH, a new chicken retroviruslike element. J Virol (1992) 0.93
Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein. Proc Natl Acad Sci U S A (2001) 0.93
Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol (1995) 0.93
Regulation and mechanisms of gene amplification. Philos Trans R Soc Lond B Biol Sci (1995) 0.91
Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res (1995) 0.90
Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res (1983) 0.90
Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol (1986) 0.89
Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34. Somat Cell Mol Genet (1997) 0.89
Variety of endogenous proviruses in the genomes of chickens of different breeds. J Gen Virol (1981) 0.88
Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys (1995) 0.88
Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines. Int J Cancer (1993) 0.87
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother (1993) 0.85
Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx. Auris Nasus Larynx (2002) 0.85
[Functional heterogeneity of p53-responsive elements]. Mol Biol (Mosk) (1996) 0.85
Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors. Mod Pathol (1989) 0.85
Retrospective DNA analysis of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1986) 0.84
Cell transforming genes and tumor progression: in vivo unified secondary phenotypic cell changes. Int J Cancer (1998) 0.84
Pathology of superficial bladder cancer with emphasis on carcinoma in situ. Urology (1985) 0.84
Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studies. Virchows Arch A Pathol Anat Histol (1981) 0.84
A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer (2010) 0.84
Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx. Laryngoscope (1999) 0.84
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest. Leukemia (2006) 0.84
Could p53 be a target for therapeutic suppression? Semin Cancer Biol (1998) 0.84
Variability in the expression of the O(H) antigen in human transitional epithelium. J Urol (1981) 0.84
Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues. Clin Cancer Res (1997) 0.83
Gene amplification in Djungarian hamster cell lines possessing decreased plasma membrane permeability for colchicine and some other drugs. Chromosoma (1985) 0.82
Expression of erbB receptors and their ligands in breast cancer: implications to biological behavior and therapeutic response. Breast Dis (2000) 0.82
Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method. Am J Clin Pathol (1981) 0.82
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate. Int J Cancer (1996) 0.82
ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol Endocrinol (2014) 0.82
Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation. J Nucl Med (1990) 0.82
Mechanisms of unusually high antioxidant activity of RSV-SR-transformed cells and of its suppression by activated p21ras. Int J Cancer (1996) 0.81
Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int J Cancer (1996) 0.81
ABO blood type predicts the cytolocalization of anti-P-glycoprotein monoclonal antibody reactivity in human colon and ureter. Hum Pathol (1990) 0.81
Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck (2001) 0.81
Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response. Cancer Res (1998) 0.81
Precision of DNA flow cytometry in inter-institutional analyses. Cytometry (1991) 0.81
Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope (1998) 0.80
The Bloom syndrome protein interacts and cooperates with p53 in regulation of transcription and cell growth control. Oncogene (2001) 0.80
[Heat shock protein of HSP70 family revealed in some contemporary freshwater Amoebae and in Acanthamoeba sp. from cysts isolated from permafrost samples]. Tsitologiia (2006) 0.80
Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol (1997) 0.80
[The genome of chickens free of endogenous avian leukosis-sarcoma proviruses contains sequences distantly related to Rous sarcoma virus]. Mol Gen Mikrobiol Virusol (1987) 0.80
Nucleolar organizer regions in squamous cell carcinoma of the head and neck. Laryngoscope (1992) 0.80
Origin of multiple "primary" colon carcinomas. A retrospective flow cytometric study. Cancer (1986) 0.80
Distribution of mouse mammary tumor virus-related sequences does not correlate with the taxonomic position of their hosts. Virus Genes (1990) 0.80
Regular pattern of karyotypic alterations accompanying gene amplification in Djungarian hamster cells: study of colchicine, adriablastin, and methotrexate resistance. Chromosoma (1985) 0.79
Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts. Oncol Res (1995) 0.79
Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents. Int J Cancer (1995) 0.79
Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis. Cancer (1986) 0.79
Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 0.79
Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network. Cancer (1989) 0.78
[Expression of human urokinase in inoculated rodent cells. Loss of introns during gene transfer using a retroviral vector]. Mol Biol (Mosk) (1992) 0.78
Viable protozoa in late Pleistocene and Holocene permafrost sediments. Dokl Biol Sci (2005) 0.78
Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival. Horm Cancer (2013) 0.78
Multiparameter flow cytometric analysis of colon polyps. Am J Clin Pathol (1987) 0.78